ROLKE JAMES (Chief Executive Officer) reported 1 transaction at REVELATION BIOSCIENCES, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/5/2026ACC: 0001193125-26-039690
DirectorOfficer· Chief Executive Officer
Since Jan 2022
-8.52K
Net shares
Net seller
$15.8K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
8.52K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−8.52K
Price / share
$1.86
Trade value
$15.85K
% of position
3.7%
2/3/2026
233.37K→224.85K
Total
Net shares
−8.52K
Net value
-$15.85K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/3/2026 | F · Tax Withholding | −8.52K | $1.86 | $15.85K | 3.7% | 233.37K | 224.85K |
| Total | −8.52K | -$15.85K | ||||||
Derivative Transactions0
No derivative transactions reported